Researchers are excited about this new drug, a groundbreaking dual compound showing significant data in initial trials for body management. It functions by impacting both pathways : GLP-1 and GIP, that , when engaged , help regulate appetite and enhance energy expenditure . Initial findings demonstrate substantial size loss and possible benefits fo